Figure 1.
Figure 1. Anti-CD20 mAbs. Schematic illustrating AME-B with modifications to enhance affinity to CD20 and AME-D with modifications to enhance affinity to both CD20 and CD16.

Anti-CD20 mAbs. Schematic illustrating AME-B with modifications to enhance affinity to CD20 and AME-D with modifications to enhance affinity to both CD20 and CD16.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal